B1: RPE rupture. Choroidal vascularization can be seen in the area where there is no RPE and a dark area towards the nasal that corresponds to the coiled RPE.
C1: onset of fibrosis after 6 months of follow-up
D1: severe macular fibrosis with pigment deposition after 2 years of follow-up
B2 (blue AF): The area where there is no RPE is hypoAF while the coiled RPE is seen as a hyperAF zone.
C2 (green AF): appearance after 6 months of follow-up
D2 (green AF): appearance after 2 years of follow-up
A: DEP with fibrovascular and serous component
B3: RPE rupture with rolling towards the nasal
C3: onset of subretinal fibrosis after 6 months of follow-up
D3: severe subretinal fibrosis after 2 years of follow-up
Type 1 macular neovascularization. OCT shows a large PED with dual components, fibrovascular and serous, as well as perilesional subretinal fluid (A).
After 1 intravitreal injection of anti-VEGF, a tear of the RPE with rolling of the same towards the nasal is observed (B).
VA remains at 20/100 for a few months, but progression to subretinal fibrosis leaves poor hand movement VA after 6 months (C) and 2 years of follow-up (D).
Comments
RPE tears are a complication of fibrovascular PEDs after treatment with antiangiogenic agents (14-20% of cases), although they can occur spontaneously (10-12% in natural history studies of the disease). The main risk factors are a large linear diameter of the PED, a high height of the PED and a prolonged evolution time of the PED. To date, there is no preventive strategy for RPE tears and no antiangiogenic agent has shown a lower risk of causing them than others. The long-term functional prognosis is very poor.
Indication
Usamos cookies para asegurar que te damos la mejor experiencia en nuestra web. Si continúas usando este sitio, asumiremos que estás de acuerdo con ello.